PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer

The outlook for patients with pancreatic cancer remains dismal. Treatment options are limited and chemotherapy remains standard of care, leading to only modest survival benefits. Hence, there is a great need to further explore the mechanistic basis for the intrinsic therapeutic resistance of this di...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson Hau, Sofie, Wahlin, Sara, Cervin, Sophie, Falk, Vilgot, Nodin, Björn, Elebro, Jacob, Eberhard, Jakob, Moran, Bruce, Gallagher, William M, Karnevi, Emelie, Jirström, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682941/
https://www.ncbi.nlm.nih.gov/pubmed/34379360
http://dx.doi.org/10.1002/cjp2.238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682941/
https://www.ncbi.nlm.nih.gov/pubmed/34379360
http://dx.doi.org/10.1002/cjp2.238

Ejemplares similares